A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors

被引：30
|
作者：
Rani, Sudesh [1 ]
Raheja, Konpal [1 ]
Luxami, Vijay [1 ]
Paul, Kamaldeep [1 ]
机构：
[1] Thapar Inst Engn & Technol, Sch Chem & Biochem, Patiala 147001, Punjab, India
来源：
BIOORGANIC CHEMISTRY | 2021年 / 113卷
关键词：
Non-steroidal aromatase; Structure-activity relationship; Breast cancer; Heterocycles; Medicinal chemistry; BREAST-CANCER; MOLECULAR DOCKING; BIOLOGICAL CHARACTERIZATION; SELECTIVE INHIBITORS; ADJUVANT TREATMENT; ESTROGEN-RECEPTOR; HIGHLY POTENT; DERIVATIVES; TAMOXIFEN; MECHANISM;
D O I：
10.1016/j.bioorg.2021.105017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Breast cancer, emerging malignancy is common among women due to overexpression of estrogen. Estrogens are biosynthesized from androgens by aromatase, a cytochrome P450 enzyme complex, and play a pivotal role in stimulating cell proliferation. Therefore, deprivation of estrogen by blocking aromatase is considered as the effective way for the inhibition and treatment of breast cancer. In recent years, various non-steroidal heterocyclic functionalities have been extensively developed and studied for their aromatase inhibition activity. This review provides information about the structural-activity relationship of heterocycles (Type II) towards aromatase. This aids the medicinal chemist around the significance of different heterocyclic moieties and helps to design potent aromatase inhibitors.
引用
收藏
页数：27
相关论文
共 50 条
  • [31] Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors
    Dai, Yujie
    Wang, Qiang
    Zhang, Xiuli
    Jia, Shiru
    Zheng, Heng
    Feng, Dacheng
    Yu, Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (12) : 5612 - 5620
  • [32] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Bahrami, Nazli
    Jabeen, Shakila
    Tahiri, Andliena
    Sauer, Torill
    Odegard, Hilde Presterud
    Geisler, Stephanie Beate
    Gravdehaug, Berit
    Reitsma, Laurens Cornelus
    Selsas, Knut
    Kristensen, Vessela
    Geisler, Jurgen
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (03) : 435 - 449
  • [33] Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1
    Fusi, Camilla
    Materazzi, Serena
    Benemei, Silvia
    Coppi, Elisabetta
    Trevisan, Gabriela
    Marone, Ilaria M.
    Minocci, Daiana
    De Logu, Francesco
    Tuccinardi, Tiziano
    Di Tommaso, Maria Rosaria
    Susini, Tommaso
    Moneti, Gloriano
    Pieraccini, Giuseppe
    Geppetti, Pierangelo
    Nassini, Romina
    NATURE COMMUNICATIONS, 2014, 5
  • [34] Pharmacophore modeling, virtual screening, and 3D-QSAR studies on a series of non-steroidal aromatase inhibitors
    Xie, Huiding
    Qiu, Kaixiong
    Xie, Xiaoguang
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (05) : 1901 - 1915
  • [35] R-76713, A NEW SPECIFIC NON-STEROIDAL AROMATASE INHIBITOR
    WOUTERS, W
    DECOSTER, R
    KREKELS, M
    VANDUN, J
    BEERENS, D
    HAELTERMAN, C
    RAEYMAEKERS, A
    FREYNE, E
    VANGELDER, J
    VENET, M
    JANSSEN, PAJ
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 32 (06): : 781 - 788
  • [36] Pharmacophore modeling, virtual screening, and 3D-QSAR studies on a series of non-steroidal aromatase inhibitors
    Huiding Xie
    Kaixiong Qiu
    Xiaoguang Xie
    Medicinal Chemistry Research, 2015, 24 : 1901 - 1915
  • [37] Pharmacogenetic study of exemestane and everolimus in metastatic breast cancer patients progressing on prior non-steroidal aromatase inhibitors
    Pascual-Martinez, T.
    Apellaniz-Ruiz, M.
    Pernaut, C.
    Cueto-Felgueroso, C.
    Villalba, P.
    Alvarez, C.
    Manso, L.
    Rodriguez-Antona, C.
    Ciruelos, E. M.
    CANCER RESEARCH, 2016, 76
  • [38] Exploring Potential Non-steroidal Aromatase Inhibitors for Therapeutic Application against Estrogen-dependent Breast Cancer
    Pandey, Khushboo
    Lokhande, Kiran Bharat
    Saha, Achintya
    Goja, Arvind
    Swamy, Kakumani Venkateswara
    Nagar, Shuchi
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2023, 19 (04) : 243 - 257
  • [39] Comparative molecular field analysis of non-steroidal aromatase inhibitors: An extended model for two different structural classes
    Recanatini, M
    Cavalli, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (04) : 377 - 388
  • [40] Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors
    Cavalli, A
    Greco, G
    Novellino, E
    Recanatini, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (12) : 2771 - 2780
12345